Techcomp Announces Plans for Chinese Health Care Market

These plans capitalize on Techcomp’s strong position in the Chinese laboratory products market and the Chinese government’s massive investments in health care (see IBO 1/31/09), which include the construction of 2,000 hospitals and 29,000 township clinics.

Singapore and Hong Kong, 9/30/10—Lab product manufacturer and distributor Techcomp has announced that it plans to expand its presence in the Chinese health care market. The company will introduce new diagnostic products, including a CE-marked microplate reader and automatic immunoassay system. In addition, Techcomp will establish a new division in its sales channel for the market, stating that it is well positioned to capture the mid-high tier market due to foreign-alliance R&D capabilities and domestic-manufacturing capacity. The company noted success in providing biological safety cabinets to Chinese hospitals and will inaugurate a new Chinese manufacturing facility for the products next month.

< | >